These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10047640)

  • 21. Plasma clearance of polyfructosan and extracellular body fluid distribution in idiopathic dilated cardiomyopathy and after heart transplantation.
    Galatius S; Bent-Hansen L; Wroblewski H; Kastrup J
    Am J Cardiol; 2000 Apr; 85(7):843-8. PubMed ID: 10758924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation.
    Parodi O; De Maria R; Oltrona L; Testa R; Sambuceti G; Roghi A; Merli M; Belingheri L; Accinni R; Spinelli F
    Circulation; 1993 Aug; 88(2):509-22. PubMed ID: 8339413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac allograft systolic function. Is the aetiology (ischaemic or idiopathic) a determinant of ventricular function in the heart transplant patient?
    Antunes MJ; Biernat M; Sola E; Oliveira L; Prieto D; Franco F; Providência LA
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):586-90; discussion 590. PubMed ID: 18469010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Aukrust P; Ueland T; Lien E; Bendtzen K; Müller F; Andreassen AK; Nordøy I; Aass H; Espevik T; Simonsen S; Frøland SS; Gullestad L
    Am J Cardiol; 1999 Feb; 83(3):376-82. PubMed ID: 10072227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Choi BR; Kim JS; Yang YJ; Park KM; Lee CW; Kim YH; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
    Am J Cardiol; 2006 May; 97(9):1365-9. PubMed ID: 16635612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
    Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
    Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral Vascular Function in Dilated Cardiomyopathy of Different Etiology.
    Bosso G; Valvano A; Apuzzi V; Mercurio V; Di Simone V; Cittadini A; Napoli R; Oliviero U
    Angiology; 2020 Sep; 71(8):726-733. PubMed ID: 32551954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. vWf levels as a circulating marker of endothelial dysfunction in patients with hypertrophic cardiomyopathy.
    Varol E; Ozaydin M; Sahin M; Altinbas A; Kosar F
    Indian Heart J; 2005; 57(6):655-7. PubMed ID: 16521632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy].
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Aschermann M; Horký K
    Vnitr Lek; 2002 Aug; 48(8):718-23. PubMed ID: 12425201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability in heart failure.
    Musialik-Łydka A; Sredniawa B; Pasyk S
    Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endothelin, endothelial cells and von Willebrand factor in peripheral blood of asthmatic patients].
    Krasnowska M; Nittner-Marszalska M; Krasnowski R; Kopeć W
    Pol Merkur Lekarski; 2002 Jun; 12(72):445-8. PubMed ID: 12362657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected markers of endothelial dysfunction in women with polycystic ovary syndrome.
    Foltyn W; Strzelczyk J; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Blicharz-Dorniak J; Kos-Kudła B
    Endokrynol Pol; 2011; 62(3):243-8. PubMed ID: 21717407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.
    Cambronero F; Vilchez JA; García-Honrubia A; Ruiz-Espejo F; Moreno V; Hernández-Romero D; Bonacasa B; González-Conejero R; de la Morena G; Martínez P; Climent V; Valdés M; Marín F
    Thromb Res; 2010 Jul; 126(1):e46-50. PubMed ID: 20156645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.